Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

AscellaHealth Supports Rare Disease Patients and Caregivers in Observance of Rare Disease Day, February 28

BERWYN, Pa., Feb. 26, 2025 (GLOBE NEWSWIRE) -- AscellaHealth, a global partner delivering customizable solutions to support the specialty pharmaceutical industry, reaffirms its commitment to supporting the 300 million individuals worldwide affected by rare diseases. In recognition of Rare Disease Day, held annually on the last day of February, the AscellaHealth team participates in this global initiative to raise awareness about rare diseases and highlight the strength and unity within these communities. Emphasizing the need for equitable access to care, AscellaHealth acknowledges that over 6,000 rare diseases are known, 72% of which are genetic, and 70% of genetic rare diseases begin in childhood.

"The mission of AscellaHealth is closely aligned with the goals of Rare Disease Day, placing patients at the forefront and standing in solidarity with the rare disease community,” says Dea Belazi, CEO, AscellaHealth. “Every day, our team works to advance customized clinical programs and services that support rare disease research, expedite diagnosis and treatment, and enhance therapeutic outcomes and access to novel therapies. Although rare diseases may affect smaller patient populations individually, they still impact millions and pose significant challenges to society.”

Belazi points to AscellaHealth’s end-to-end solutions that accelerate the discovery and commercialization of life-changing therapies that improve the lives of rare disease patients globally.

AscellaHealth collaborates with specialty pharmaceutical manufacturers worldwide to advance innovative research and accelerate the launch of groundbreaking cell and gene therapies (CGTs) that have the potential to cure or slow the progression of rare diseases. The Company’s expert teams also work closely with payers to explore reimbursement strategies and benefit management approaches that enhance access to high-cost treatments. Dedicated to delivering comprehensive solutions, AscellaHealth helps improve operational efficiency, broaden access and drive better outcomes for members.

In honor of Rare Disease Day, and as part of our ongoing Podcast Pulse series, AscellaHealth has produced a special podcast that showcases inspiring stories from patients who have benefited from the support of our dedicated care coordinators throughout their rare disease journey. We celebrate their strength and resilience, proudly amplifying their voices in recognition of this meaningful day.

About AscellaHealth LLC
AscellaHealth is a global partner that delivers proven end-to-end solutions to both life sciences and healthcare companies to enhance the quality of life for patients with complex, chronic conditions. A dedicated team gets critical healthcare products from manufacturers to patients while ensuring an efficient flow of funds between payers and pharma. Visit www.AscellaHealth.com.


Media:
Nicole Dufour
CPR Communications
ndufour@cpronline.com
201.641.1911 x 54

Primary Logo

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.